Chantale Bernatchez

Chantale Bernatchez

UNVERIFIED PROFILE

Are you Chantale Bernatchez?   Register this Author

Register author
Chantale Bernatchez

Chantale Bernatchez

Publications by authors named "Chantale Bernatchez"

Are you Chantale Bernatchez?   Register this Author

58Publications

2225Reads

47Profile Views

Potential clinical application of tumor-infiltrating lymphocyte therapy for ovarian epithelial cancer prior or post-resistance to chemotherapy.

Cancer Immunol Immunother 2019 Oct 10. Epub 2019 Oct 10.

Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (UT MDACC), Unit 904, 7455 Fannin, Houston, TX, 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00262-019-02402-zDOI Listing
October 2019

Exposure to anti-PD-1 causes functional differences in tumor-infiltrating lymphocytes in rare solid tumors.

Eur J Immunol 2019 Sep 18. Epub 2019 Sep 18.

Department of Investigational Therapeutics, The University of Texas MDACC, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201948217DOI Listing
September 2019

TIL therapy and anti-CTLA4: can they co-exist?

Oncotarget 2019 Jan 1;10(1):1-2. Epub 2019 Jan 1.

Chantale Bernatchez: Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center (MDACC), Houston, TX, USA; Department of Translational Molecular Pathology, The University of Texas MDACC, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/26509
Publisher Site
http://dx.doi.org/10.18632/oncotarget.26509DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6343756PMC
January 2019

Resident Breast T Cells: The Troops Are Already There.

Trends Mol Med 2018 10 1;24(10):821-822. Epub 2018 Aug 1.

Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Graduate School of Biomedical Sciences, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molmed.2018.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6168353PMC
October 2018

T-cell Homing Therapy for Reducing Regulatory T Cells and Preserving Effector T-cell Function in Large Solid Tumors.

Clin Cancer Res 2018 06 1;24(12):2920-2934. Epub 2018 Feb 1.

Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-1365DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004229PMC
June 2018

Targeting the HGF/MET Axis Counters Primary Resistance to KIT Inhibition in -Mutant Melanoma.

JCO Precis Oncol 2018 5;2018. Epub 2018 Jun 5.

Junna Oba, Sun-Hee Kim, Wei-Lien Wang, Mariana P. Macedo, Fernando Carapeto, Meredith A McKean, John Van Arnam, Agda K. Eterovic, Shiraj Sen, Charuta R. Kale, Xiaoxing Yu, Cara L. Haymaker, Mark Routbort, Lauren E. Haydu, Chantale Bernatchez, Alexander J. Lazar, Elizabeth A. Grimm, David S. Hong, and Scott E. Woodman, The University of Texas MD Anderson Cancer Center, Houston, TX; and Mariana P. Macedo, AC Camargo Cancer Center, São Paulo, Brazil.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080631PMC
http://dx.doi.org/10.1200/PO.18.00055DOI Listing
June 2018

Immune-Modulation by Epidermal Growth Factor Receptor Inhibitors: Implication on Anti-Tumor Immunity in Lung Cancer.

PLoS One 2016 28;11(7):e0160004. Epub 2016 Jul 28.

Division of Oncology, Department of Medicine, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0160004PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965069PMC
August 2017

Induction of NKG2D Ligands on Solid Tumors Requires Tumor-Specific CD8 T Cells and Histone Acetyltransferases.

Cancer Immunol Res 2017 04 21;5(4):300-311. Epub 2017 Feb 21.

Department of Pediatrics-Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-16-0234DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382872PMC
April 2017

Loss of IFN-γ Pathway Genes in Tumor Cells as a Mechanism of Resistance to Anti-CTLA-4 Therapy.

Cell 2016 Oct 22;167(2):397-404.e9. Epub 2016 Sep 22.

Department of Genitourinary Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5088716PMC
http://dx.doi.org/10.1016/j.cell.2016.08.069DOI Listing
October 2016

Novel Treatments in Development for Melanoma.

Cancer Treat Res 2016 ;167:371-416

University of Texas MD Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-3-319-22539-5_16DOI Listing
January 2016

Activation and propagation of tumor-infiltrating lymphocytes on clinical-grade designer artificial antigen-presenting cells for adoptive immunotherapy of melanoma.

J Immunother 2014 Nov-Dec;37(9):448-60

*Department of Melanoma Medical Oncology †Division of Pediatrics, MD Anderson Cancer Center, Houston, TX ‡Infectious Disease and Immunogenetics Section, Department of Transfusion Medicine, Clinical Center and trans-NIH Center for Human Immunology, National Institutes of Health, Bethesda, MD ∥Lion Biotechnologies, Woodland Hills, CA §Sidra Medical and Research Hospital, Doha, Qatar.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000056DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4199393PMC
November 2015

BTLA marks a less-differentiated tumor-infiltrating lymphocyte subset in melanoma with enhanced survival properties.

Oncoimmunology 2015 Aug 16;4(8):e1014246. Epub 2015 Mar 16.

Department of Melanoma Medical Oncology; The University of Texas MD Anderson Cancer Center ; Houston, TX USA ; Lion Biotechnologies ; Tampa, FL USA ; Department of Immunology; H Lee Moffitt Cancer Center ; Tampa, FL USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/2162402X.2015.1014246DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570103PMC
August 2015

BRAFV600E Co-opts a Conserved MHC Class I Internalization Pathway to Diminish Antigen Presentation and CD8+ T-cell Recognition of Melanoma.

Cancer Immunol Res 2015 Jun 20;3(6):602-9. Epub 2015 Mar 20.

Department of Melanoma Medical Oncology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas. Department of Immunology, Center for Cancer Immunology Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0030DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4457616PMC
June 2015

Advances in the development of cancer immunotherapies.

Trends Immunol 2013 Feb 30;34(2):90-8. Epub 2012 Sep 30.

Center for Cancer Immunology Research, GU and Melanoma Medical Oncology Department, MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.it.2012.08.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565019PMC
February 2013

A new approach to simultaneously quantify both TCR α- and β-chain diversity after adoptive immunotherapy.

Clin Cancer Res 2012 Sep 3;18(17):4733-42. Epub 2012 Jul 3.

Department of Melanoma Medical Oncology, Unit 904, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-3234DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3823368PMC
September 2012

PD-1 and BTLA and CD8(+) T-cell "exhaustion" in cancer: "Exercising" an alternative viewpoint.

Oncoimmunology 2012 Aug;1(5):735-738

Department of Melanoma Medical Oncology; University of Texas; MD Anderson Cancer Center; Houston, TX USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/onci.20823DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3429577PMC
August 2012

Advances in the treatment of metastatic melanoma: adoptive T-cell therapy.

Semin Oncol 2012 Apr;39(2):215-26

Department of Melanoma Medical Oncology, The University of Texas, M.D. Anderson Cancer Center, Houston, TX 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2012.01.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3500663PMC
April 2012

Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2.

Blood 2003 Oct 26;102(8):2901-9. Epub 2003 Jun 26.

Centre de Recherche en Rhumatologie et Immunologie, Université Laval, QC G1V 4G2, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-12-3702DOI Listing
October 2003